Avalo Therapeutics (C6K0.MU) Q3 2026 Earnings

30JulConfirmed
Q1 2026
Next
-1.26
-1.05
-0.85
-0.65

Details

Expected EPS
-0.736152444
Actual EPS
N/A
Surprise EPS
0.74
Surprise Percent
+100%

Description

Avalo Therapeutics (C6K0.MU) will report earnings of for Q3 2026 on July 30, 2026.

0 Comments

Share your thoughts